πŸ‡ΊπŸ‡Έ FDA
Patent

US 11612575

Combination therapies with disulfiram

granted A61KA61K31/11A61K31/145

Quick answer

US patent 11612575 (Combination therapies with disulfiram) held by Spring Discovery, Inc. expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Spring Discovery, Inc.
Grant date
Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/11, A61K31/145, A61K39/39, A61P